Michael Timm

3.7k total citations
76 papers, 2.3k citations indexed

About

Michael Timm is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Michael Timm has authored 76 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 33 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Michael Timm's work include Multiple Myeloma Research and Treatments (33 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Michael Timm is often cited by papers focused on Multiple Myeloma Research and Treatments (33 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Michael Timm collaborates with scholars based in United States, Denmark and Germany. Michael Timm's co-authors include Erik W. Hansen, S. Vincent Rajkumar, Shaji Kumar, Philip R. Greipp, Thomas E. Witzig, Anne Mette Madsen, Mika Frankel, Teresa K. Kimlinger, Lise Moesby and Janine Haug and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Applied and Environmental Microbiology.

In The Last Decade

Michael Timm

70 papers receiving 2.3k citations

Peers

Countries citing papers authored by Michael Timm

Since Specialization

Citations

This map shows the geographic impact of Michael Timm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Timm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Timm more than expected).

Fields of papers citing papers by Michael Timm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Timm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Timm. The network helps show where Michael Timm may publish in the future.

Co-authorship network of co-authors of Michael Timm

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Timm. A scholar is included among the top collaborators of Michael Timm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Timm. Michael Timm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia 2025 ·Cancers ·(unknown), Gregory E. Otteson, Michael Timm, (unknown), Min Shi, Pedro Horna, Dragan Jevremović, Kaaren K. Reichard, Horatiu Olteanu	0
2	Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry 2025 ·Cancers ·Jansen N. Seheult, Gregory E. Otteson, (unknown), Michael Timm, (unknown), Dragan Jevremović, Pedro Horna, Horatiu Olteanu, Min Shi	2
3	Safety and efficiency evaluation of an innovative plasma jet array in argon using gas switching technology 2025 ·Journal of Physics D Applied Physics ·(unknown), (unknown), Stefan Horn, Michael Timm, Veronika Hahn, (unknown), (unknown), (unknown), Thomas von Woedtke, (unknown), Torsten Gerling	1
4	Establishing NK-Cell Receptor Restriction by Flow Cytometry and Detecting Potential NK-Cell Clones of Uncertain Significance 2023 ·Modern Pathology ·Jansen N. Seheult, Gregory E. Otteson, Dragan Jevremović, Pedro Horna, Michael Timm, Yuan Ji, William G. Morice, Horatiu Olteanu, Min Shi	5
5	Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma 2019 ·Blood Cancer Journal ·James B. Smadbeck, Jess F. Peterson, Kathryn E. Pearce, Beth A. Pitel, (unknown), Michael Timm, Dragan Jevremović, Min Shi, A. Keith Stewart, Esteban Braggio, Daniel L. Riggs, P. Leif Bergsagel, George Vasmatzis, Hutton M. Kearney, Nicole L. Hoppman, Rhett P. Ketterling, Shaji Kumar, S. Vincent Rajkumar, Patricia T. Greipp, Linda B. Baughn	29
6	Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation 2018 ·Haematologica ·M Hasib Sidiqi, Mohammed A. Aljama, Dragan Jevremović, William G. Morice, Michael Timm, Francis K. Buadi, Rahma Warsame, Martha Q. Lacy, Angela Dispenzieri, David Dingli, Wilson I. Gonsalves, Shaji Kumar, Prashant Kapoor, Taxiarchis Kourelis, Nelson Leung, William J. Hogan, Morie A. Gertz	3
7	Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response 2018 ·Bone Marrow Transplantation ·M Hasib Sidiqi, Mohammed A. Aljama, Dragan Jevremović, William G. Morice, Michael Timm, Francis K. Buadi, Rahma Warsame, Martha Q. Lacy, Angela Dispenzieri, David Dingli, Wilson I. Gonsalves, Shaji Kumar, Prashant Kapoor, Taxiarchis Kourelis, Nelson Leung, William J. Hogan, Eli Muchtar, John A. Lust, S. Vincent Rajkumar, Morie A. Gertz	5
8	Sampling, extraction and measurement of bacteria, endotoxin, fungi and inflammatory potential of settling indoor dust 2012 ·Journal of Environmental Monitoring ·Anne Mette Madsen, (unknown), Margit W. Frederiksen, Marie Frederiksen, Mika Frankel, Michal Spilak, Lars Gunnarsen, Michael Timm	61
9	Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine 2012 ·Cancer Chemotherapy and Pharmacology ·Hannelouise Kissow, Niels‐Erik Viby, Bolette Hartmann, Jens J. Holst, Michael Timm, Lars Thim, Steen Seier Poulsen	37
10	Immunomodulatory effects of testosterone evaluated in all-trans retinoic acid differentiated HL-60 cells, granulocytes, and monocytes 2012 ·International Immunopharmacology ·(unknown), Lise Moesby, Michael Timm, Erik W. Hansen	9
11	Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs 2009 ·Oncogene ·Vijay Ramakrishnan, Michael Timm, Janine Haug, Teresa K. Kimlinger, Linda Wellik, Thomas E. Witzig, S. Vincent Rajkumar, Alex A. Adjei, Shaji Kumar	73
12	Cryopreservation of differentiated HL-60 cells for pyrogen testing 2008 ·Journal of Immunological Methods ·Michael Timm, (unknown), Lise Moesby, Erik W. Hansen	5
13	The effect of dietary fish oil-supplementation to healthy young men on oxidative burst measured by whole blood chemiluminescence 2008 ·British Journal Of Nutrition ·(unknown), Michael Timm, Camilla T. Damsgaard, Erik W. Hansen, Harald S. Hansen, Lotte Lauritzen	7
14	ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells 2007 ·Leukemia ·Michael Kline, S. Vincent Rajkumar, Michael Timm, Teresa K. Kimlinger, Janine Haug, John A. Lust, Philip R. Greipp, Shaji Kumar	129
15	Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma 2006 ·Leukemia ·Michael Timm, Teresa K. Kimlinger, Janine Haug, (unknown), Philip R. Greipp, S. Vincent Rajkumar, Shaji Kumar	18
16	Novel Analysis of Clonal Diversification in Blood B Cell and Bone Marrow Plasma Cell Clones in Immunoglobulin Light Chain Amyloidosis 2006 ·Journal of Clinical Immunology ·Roshini S. Abraham, (unknown), Neta S. Zuckerman, Abhishek Sohni, Hanna Edelman, Gitit Shahaf, Michael Timm, Angela Dispenzieri, Morie A. Gertz, Ramit Mehr	15
17	Oncolytic measles virus targets high CD46 expression on multiple myeloma cells 2006 ·Experimental Hematology ·Hooi Tin Ong, Michael Timm, Philip R. Greipp, Thomas E. Witzig, Angela Dispenzieri, Stephen J. Russell, Kah-Whye Peng	107
18	Utilization of the human cell line HL-60 for chemiluminescence based detection of microorganisms and related substances 2005 ·European Journal of Pharmaceutical Sciences ·Michael Timm, Erik W. Hansen, Lise Moesby, Jens D. Christensen	22
19	Flow Cytometric Methods for Detection and Quantifi cation of Apoptosis 2003 ·Humana Press eBooks ·David P. Steensma, Michael Timm, Thomas E. Witzig	32
20	Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders 1999 ·British Journal of Haematology ·Thomas E. Witzig, Michael Timm, Dirk R. Larson, Terry M. Therneau, Philip R. Greipp	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact